1.905
price up icon0.80%   0.005
 
loading

Finanzdaten der Erasca Inc-Aktie (ERAS)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
14.70%
38.85
33.87 34.66 35.97 37.02
Operating Income/Loss
14.70%
-38.85
-33.87 -34.66 -35.97 -37.02
Nonoperating Income/Loss
8.08%
3.834
4.171 4.297 4.189 3.826
Income/Loss From Continuing Operations Before Tax
17.90%
-35.02
-29.70 -30.36 -31.78 -33.20
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
17.90%
-35.02
-29.70 -30.36 -31.78 -33.20
Net Income/Loss
17.90%
-35.02
-29.70 -30.36 -31.78 -33.20
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
81,883%
151.16
0.1844 150.45 150.04 149.50
Diluted Average Shares
81,883%
151.16
0.1844 150.45 150.04 149.50
Basic Earnings Per Share
21.05%
-0.23
-0.19 -0.20 -0.21 -0.22
Diluted Earnings Per Share
21.05%
-0.23
-0.19 -0.20 -0.21 -0.22
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$72.30
price down icon 1.48%
$38.91
price up icon 8.49%
$371.83
price up icon 1.17%
$23.12
price up icon 4.50%
biotechnology ONC
$216.22
price down icon 1.00%
$115.51
price down icon 1.48%
Kapitalisierung:     |  Volumen (24h):